Patent · US Active

Apoptotic cell-mediated transfection of mammalian cells with interfering RNA

US8637476B2 · kind B2 · utility

0Cited by
2References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 28, 2007
Grant dateJan 28, 2014
Priority date
Expiry dateDec 6, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/531
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Mammalian host cells for use in a cell-mediated tranfection process, which contain an RNAi molecule and an expression vector for a pro-apoptotic protein. The method includes inducing apoptotic cell (AC) death in mammalian cells that contain an RNAi molecule capable of downregulating a chosen target gene. Living cells expressing the target gene are then exposed to the ACs. The ACs are processed by the living cells, and the RNAi molecule in the ACs downregulates the expression of the target gene in living cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.